Xu Qi

490 total citations
20 papers, 364 citations indexed

About

Xu Qi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Xu Qi has authored 20 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Xu Qi's work include Protein Tyrosine Phosphatases (6 papers), Galectins and Cancer Biology (4 papers) and Seaweed-derived Bioactive Compounds (3 papers). Xu Qi is often cited by papers focused on Protein Tyrosine Phosphatases (6 papers), Galectins and Cancer Biology (4 papers) and Seaweed-derived Bioactive Compounds (3 papers). Xu Qi collaborates with scholars based in China. Xu Qi's co-authors include Dayong Shi, Jiao Luo, Cheng Peng, Qichun Zhang, Huimin Bian, Qi Chen, Xichao Yu, Qinghai Meng, Renshuai Zhang and Lijun Wang and has published in prestigious journals such as British Journal of Pharmacology, Biosensors and Bioelectronics and Journal of Ethnopharmacology.

In The Last Decade

Xu Qi

17 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Qi China 10 208 46 41 38 34 20 364
Ji Hao China 15 321 1.5× 63 1.4× 27 0.7× 33 0.9× 54 1.6× 29 552
Lucia Dwi Antika Indonesia 12 133 0.6× 46 1.0× 37 0.9× 28 0.7× 36 1.1× 20 393
Bashir Ahmad Pakistan 16 205 1.0× 69 1.5× 22 0.5× 21 0.6× 21 0.6× 40 456
Sudeep Gautam India 12 140 0.7× 102 2.2× 46 1.1× 23 0.6× 51 1.5× 23 341
Nagaraj M. Kulkarni India 13 151 0.7× 43 0.9× 42 1.0× 57 1.5× 86 2.5× 19 410
Swaraj Bandhu Kesh India 10 115 0.6× 47 1.0× 43 1.0× 19 0.5× 60 1.8× 13 371
Shuw-Yuan Lin Taiwan 8 151 0.7× 26 0.6× 18 0.4× 32 0.8× 49 1.4× 9 423
Jyotsana Pandey India 11 146 0.7× 100 2.2× 34 0.8× 20 0.5× 27 0.8× 25 341
Rihui Wu China 13 229 1.1× 33 0.7× 22 0.5× 34 0.9× 25 0.7× 43 477

Countries citing papers authored by Xu Qi

Since Specialization
Citations

This map shows the geographic impact of Xu Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Qi more than expected).

Fields of papers citing papers by Xu Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Qi. The network helps show where Xu Qi may publish in the future.

Co-authorship network of co-authors of Xu Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Qi. A scholar is included among the top collaborators of Xu Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Qi. Xu Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qi, Xu, Chuanyu Li, Zhiqi Zhang, et al.. (2024). Self-correction of cycle threshold values by a normal distribution–based process to improve accuracy of quantification in real-time digital PCR. Analytical and Bioanalytical Chemistry. 416(10). 2453–2464. 1 indexed citations
2.
Qi, Xu, Jinze Li, Qi Yang, et al.. (2023). Precise determination of reaction conditions for accurate quantification in digital PCR by real-time fluorescence monitoring within microwells. Biosensors and Bioelectronics. 244. 115798–115798. 8 indexed citations
3.
Chen, Xuesong, Wangjian Zha, Mei Su, et al.. (2023). Persistent response of furmonertinib plus anlotinib in a lung adenocarcinoma patient with an EGFR exon 20 insertion mutation: A case report. Frontiers in Pharmacology. 14. 1053805–1053805. 2 indexed citations
4.
Qi, Xu, Hui Kong, Ningfei Ji, et al.. (2021). Abnormal Coagulation Function of Patients With COVID-19 Is Significantly Related to Hypocalcemia and Severe Inflammation. Frontiers in Medicine. 8. 638194–638194. 15 indexed citations
5.
Meng, Qinghai, Xu Qi, Ying Chao, et al.. (2020). IRS1/PI3K/AKT pathway signal involved in the regulation of glycolipid metabolic abnormalities by Mulberry (Morus alba L.) leaf extracts in 3T3-L1 adipocytes. Chinese Medicine. 15(1). 1–1. 70 indexed citations
6.
Kong, Hui, Xu Qi, Ningfei Ji, et al.. (2020). Carcinoembryonic Antigen: A Potential Biomarker to Evaluate the Severity and Prognosis of COVID-19. Frontiers in Medicine. 7. 579543–579543. 9 indexed citations
7.
Zha, Wangjian, et al.. (2020). Efficacy and safety of flexible endoscopic intervention via laryngeal mask airway for endobronchial hamartoma removal. Minimally Invasive Therapy & Allied Technologies. 30(3). 139–146.
8.
Li, Xiangqian, Xu Qi, Chao Li, et al.. (2019). Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors. European Journal of Medicinal Chemistry. 166. 178–185. 21 indexed citations
10.
Meng, Qinghai, Xu Qi, Yu Fu, et al.. (2019). Flavonoids extracted from mulberry (Morus alba L.) leaf improve skeletal muscle mitochondrial function by activating AMPK in type 2 diabetes. Journal of Ethnopharmacology. 248. 112326–112326. 113 indexed citations
11.
Zhang, Yuan, et al.. (2018). Posterior Inferior Cerebellar Artery Aneurysm. Academic Radiology. 25(12). 1564–1567. 6 indexed citations
12.
Zhang, Renshuai, Rilei Yu, Xu Qi, et al.. (2017). Discovery and evaluation of the hybrid of bromophenol and saccharide as potent and selective protein tyrosine phosphatase 1B inhibitors. European Journal of Medicinal Chemistry. 134. 24–33. 26 indexed citations
13.
Qi, Xu, Jiao Luo, Ning Wu, Renshuai Zhang, & Dayong Shi. (2017). BPN, a marine-derived PTP1B inhibitor, activates insulin signaling and improves insulin resistance in C2C12 myotubes. International Journal of Biological Macromolecules. 106. 379–386. 21 indexed citations
14.
Li, Xiangqian, Xu Qi, Jiao Luo, et al.. (2017). Design, synthesis and biological evaluation of uncharged catechol derivatives as selective inhibitors of PTP1B. European Journal of Medicinal Chemistry. 136. 348–359. 19 indexed citations
15.
Luo, Jiao, Xu Qi, Bo Jiang, et al.. (2017). Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor. British Journal of Pharmacology. 175(1). 140–153. 25 indexed citations
16.
Qi, Xu, Lijun Wang, Jiao Luo, & Dayong Shi. (2017). The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade. Current Drug Targets. 19(1). 55–69. 8 indexed citations
17.
Wang, Shuaiyu, Lijun Wang, Bo Jiang, et al.. (2015). Synthesis and biological evaluation of novel fluorinated anticancer agents incorporating the indolin-2-one moiety. RSC Advances. 5(111). 91795–91801. 10 indexed citations
18.
Qi, Xu. (2013). Advances on Research and Utilization of Tea Tree (Camellia sinensis) Anthocyanins and Its Germplasm Resources. 1 indexed citations
19.
Huang, Mao, et al.. (2013). [Flexible bronchoscopic intervention for endobronchial hamartoma].. PubMed. 36(12). 963–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026